MoneyWorks4Me

A fair growth of 24.35% in the revenue at Rs. 5724.90 millions was reported in the March 2022 quarter as compared to Rs. 4603.80 millions during year-ago period.Net Profit of the company move down -63.12% to Rs. 277.50  millions from Rs. 752.50 millions  in the same quarter last year.The company reported a degrowth in operating Profit to 500.50 millions from 1173.80 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 5724.90 4603.80 24.35 21840.20 19669.80 11.03 21840.20 19669.80 11.03
Other Income 69.30 62.10 11.59 320.40 243.00 31.85 320.40 243.00 31.85
PBIDT 500.50 1173.80 -57.36 2883.20 6161.40 -53.21 2883.20 6161.40 -53.21
Interest 23.40 14.40 62.50 82.90 58.30 42.20 82.90 58.30 42.20
PBDT 477.10 1159.40 -58.85 2661.00 6103.10 -56.40 2661.00 6103.10 -56.40
Depreciation 110.10 99.70 10.43 432.60 389.20 11.15 432.60 389.20 11.15
PBT 367.00 1059.70 -65.37 2228.40 5713.90 -61.00 2228.40 5713.90 -61.00
TAX 89.50 307.20 -70.87 571.80 1268.30 -54.92 571.80 1268.30 -54.92
Deferred Tax 2.10 30.70 -93.16 1.70 -187.20 -100.91 1.70 -187.20 -100.91
PAT 277.50 752.50 -63.12 1656.60 4445.60 -62.74 1656.60 4445.60 -62.74
Equity 587.10 587.10 0.00 587.10 587.10 0.00 587.10 587.10 0.00
PBIDTM(%) 8.74 25.50 -65.71 13.20 31.32 -57.86 13.20 31.32 -57.86
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..